Duprost 0.5 mg contains dutasteride, a potent inhibitor of both type 1 and type 2 5‑alpha‑reductase enzymes responsible for converting testosterone to dihydrotestosterone (DHT). By suppressing DHT production, Duprost shrinks an enlarged prostate gland and relieves urinary symptoms associated with benign prostatic hyperplasia (BPH). It reduces the risk of acute urinary retention and the need for prostate surgery. Because dutasteride acts systemically, it may also reduce scalp DHT levels, but its approved use is for BPH.
The typical dosage is one 0.5 mg capsule taken once daily, swallowed whole with or without food. Do not chew or crush the capsules, as contact with the contents may irritate the oropharyngeal mucosa. Duprost may be taken alone or in combination with an alpha‑blocker such as tamsulosin for more rapid symptom improvement. Treatment is long‑term; many men require six months of therapy before noticing maximal symptom relief. Continue taking the medication even if you feel well, and do not double doses if you miss a dose—just take the next scheduled dose.
Common side effects of dutasteride include decreased libido, erectile dysfunction, ejaculatory disorders and breast tenderness or enlargement. These side effects typically resolve with continued use or upon discontinuation of the drug. Rarely, allergic reactions such as rash, swelling or difficulty breathing may occur; seek medical attention immediately if these develop. Periodic monitoring of prostate‑specific antigen (PSA) levels is recommended; dutasteride lowers PSA by approximately 50%, so any rise during therapy warrants evaluation.
Pregnant women or those trying to conceive should avoid handling crushed or leaking capsules because dutasteride is absorbed through the skin and can harm a male fetus. Men taking Duprost should not donate blood for at least six months after stopping treatment to prevent exposure to a pregnant transfusion recipient. Inform your doctor about any other medications you are taking; no significant drug‑drug interactions have been noted, but caution is advised in patients with liver impairment. For more information, visit Duprost 0.5mg.
The typical dosage is one 0.5 mg capsule taken once daily, swallowed whole with or without food. Do not chew or crush the capsules, as contact with the contents may irritate the oropharyngeal mucosa. Duprost may be taken alone or in combination with an alpha‑blocker such as tamsulosin for more rapid symptom improvement. Treatment is long‑term; many men require six months of therapy before noticing maximal symptom relief. Continue taking the medication even if you feel well, and do not double doses if you miss a dose—just take the next scheduled dose.
Common side effects of dutasteride include decreased libido, erectile dysfunction, ejaculatory disorders and breast tenderness or enlargement. These side effects typically resolve with continued use or upon discontinuation of the drug. Rarely, allergic reactions such as rash, swelling or difficulty breathing may occur; seek medical attention immediately if these develop. Periodic monitoring of prostate‑specific antigen (PSA) levels is recommended; dutasteride lowers PSA by approximately 50%, so any rise during therapy warrants evaluation.
Pregnant women or those trying to conceive should avoid handling crushed or leaking capsules because dutasteride is absorbed through the skin and can harm a male fetus. Men taking Duprost should not donate blood for at least six months after stopping treatment to prevent exposure to a pregnant transfusion recipient. Inform your doctor about any other medications you are taking; no significant drug‑drug interactions have been noted, but caution is advised in patients with liver impairment. For more information, visit Duprost 0.5mg.
0